Evaluating the Engineering Challenges & Strategies for Novel Viral Platforms to Overcome These Hurdles & Streamline Your OV Candidates into the Clinics
Time: 9:30 am
day: Day One
Details:
- Adapting viral genomes for enhanced tumor targeting and replication
- Overcoming limitations in viral tropism and immune evasion
- Assessing potential off-target effects and toxicity of novel viral platforms
- Designing and optimizing viral modifications to minimize non-specific tissue damage
- Predictive toxicology and risk assessment approaches for early safety evaluation
